SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of marketed products includes Trokendi XR, an extended-release topiramate formulation prescribed for both epilepsy management and migraine prevention. Another key product is Oxtellar XR, an extended-release oxcarbazepine designed for the standalone treatment of partial-onset epileptic seizures in patients aged 6 to 17 and adults. The company also offers Qelbree, a selective norepinephrine reuptake inhibitor approved for attention-deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17. For advanced Parkinson's Disease (PD) patients, APOKYN offers acute, intermittent relief during "off" episodes of hypomobility, and XADAGO serves as an adjunctive treatment with levodopa/carbidopa for those experiencing similar off periods. Other offerings include GOCOVRI, which targets dyskinesia in PD patients, and Osmolex ER, used for Parkinson's disease and drug-induced extrapyramidal reactions in adults. MYOBLOC, a Type B toxin, is indicated for cervical dystonia and sialorrhea in adults. Beyond its commercial portfolio, Supernus is actively developing several investigational therapies. These include Qelbree (SPN-812), which has successfully completed Phase III trials for ADHD. SPN-830, a late-stage drug/device combination, aims to prevent off episodes in PD patients. SPN-817 is a novel compound in Phase I trials for severe epilepsy. SPN-820 is undergoing Phase II trials for resistant depression, and SPN-443 and SPN-446 are in earlier, preclinical stages for various CNS indications. Products are distributed through a network of pharmaceutical wholesalers, specialty pharmacies, and authorized distributors. Established in 2005, Supernus Pharmaceuticals is headquartered in Rockville, Maryland.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Trading halted (T12)Halted since Oct 31, 2026. Last trade $41.92. The price shown is frozen at the last trade before the halt and resumes updating when trading resumes.
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPNHealthcare · Drug Manufacturers - Specialty & Generic
+0.19%$41.92
AH$41.92+0.00%vs close
Mkt Cap$2.44B
Float55.54M
O/S58.24M
Vol
$ Vol
RVOL
Inst Own-
SI7.3%
Earnings
Dilution
Financials Summary
Revenue$718.95M
Net Income-$38.55M
Total Assets$1.45B
Free Cash Flow$45.99M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$40.98M
Total Equity$1.06B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SUPN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.45B
Liabilities$390.93M
Accounts Receivable$187.8M
Accounts Payable$2.68M
Inventory$82.39M
PP&E (Net)$10.53M
Goodwill$124.88M
Intangible Assets$569.46M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
| Revenue | $718.95M | $661.82M | $607.52M | $667.24M | $579.77M | $520.4M | $392.75M | $408.9M | $302.24M | $215M | $144.43M | $122.05M | $12.02M | $1.48M | $803K | $106K | $37.92M | $8.89M | $4.23M |
| YoY Growth | 8.6% | 8.9% | -8.9% | 15.1% | 11.4% | 32.5% | -3.9% | 35.3% | 40.6% | 48.9% | 18.3% | 915.4% | 712.1% | 84.3% | 657.5% | -99.7% | 326.7% | 110.0% | - |
| Cost of Revenue | $74.56M | $77.91M | $83.78M | $87.22M | $75.06M | $52.46M | $16.66M | $15.36M | $15.21M | $11.99M | $8.42M | $5.76M | $1.1M | $0 | $0 | -$13.4M | -$8.59M | $336 | $0 |
| Gross Profit | $644.39M | $583.91M | $523.74M | $580.02M | $504.71M | $467.94M | $376.1M | $393.54M | $287.02M | $203.02M | $136M | $116.29M | $10.91M | $1.48M | $803K | $13.51M | $46.51M | $8.89M | $4.23M |
| Gross Margin | 89.6% | 88.2% | 86.2% | 86.9% | 87.1% | 89.9% | 95.8% | 96.2% | 95.0% | 94.4% | 94.2% | 95.3% | 90.8% | 100.0% | 100.0% | 12745.3% | 122.6% | 100.0% | 100.0% |
| Research and Development | $106.23M | $108.8M | $91.59M | $74.55M | $90.47M | $75.96M | $69.1M | $89.21M | $49.58M | $42.79M | $29.14M | $19.59M | $17.25M | $23.52M | $30.63M | $35.15M | $29.26M | $30.46M | $19.27M |
| Selling, General, and Administrative | $485.56M | $335.78M | $336.36M | $377.22M | $304.76M | $200.68M | $158.43M | $159.89M | $137.91M | $106.01M | $89.2M | $72.47M | $55.59M | $20.13M | $7.93M | $5.08M | $4.65M | $4.29M | $4.01M |
| Other | $89.46M | $57.67M | $101.06M | $82.12M | $23.46M | $17.6M | $0 | $0 | $0 | -$15K | $38K | $39K | $101K | $0 | $117K | $542K | $0 | $0 | $0 |
| Total Operating Expenses | $681.25M | $502.25M | $529.01M | $533.89M | $418.69M | $294.24M | $227.52M | $249.1M | $187.48M | $148.8M | $118.34M | $92.06M | $72.83M | $43.65M | $38.55M | $40.23M | $33.91M | $34.75M | $23.28M |
| Operating Income (EBIT) | -$36.86M | $81.67M | -$5.27M | $46.12M | $86.03M | $173.7M | $148.57M | $144.44M | $99.54M | $54.22M | $17.66M | $24.23M | -$61.92M | -$42.17M | -$37.75M | -$40.12M | $4.02M | -$25.86M | -$19.05M |
| Operating Margin | -5.1% | 12.3% | -0.9% | 6.9% | 14.8% | 33.4% | 37.8% | 35.3% | 32.9% | 25.2% | 12.2% | 19.9% | -515.2% | -2849.3% | -4701.4% | -37851.9% | 10.6% | -290.9% | -449.9% |
| Interest Expense | $0 | $0 | $2.42M | $7.07M | $23.42M | $23.75M | $22.71M | $18.11M | $1.57M | $5.09M | $4.77M | $5.62M | $7.85M | $3.58M | $1.87M | $0 | $0 | $8.68M | $0 |
| Interest Income | $13.25M | $16.2M | $10.45M | $21.69M | $10.57M | $18.7M | $21.62M | $13.84M | $2.65M | $1.48M | $681K | $348K | $299K | $120K | $31K | $107K | $122K | $1.06M | $1.77M |
| Other Income (Expense) | -$12.17M | $16.2M | $8.04M | $14.62M | -$12.85M | -$5.05M | -$1.08M | -$4.27M | $1.08M | -$3.85M | -$6.23M | -$4.36M | -$30.35M | -$4.12M | -$1.72M | $649K | $122K | -$7.62M | $1.77M |
| Income Before Tax (EBT) | -$49.03M | $97.87M | $2.77M | $60.74M | $73.17M | $168.65M | $147.49M | $140.18M | $100.62M | $50.37M | $14.97M | $19.87M | -$92.27M | -$46.28M | -$39.47M | -$39.47M | $4.14M | -$33.48M | -$17.27M |
| Income Tax Expense | -$10.48M | $24M | $1.45M | $32K | $19.75M | $41.7M | $34.43M | $29.18M | $43.33M | -$40.85M | $956K | $0 | $0 | $0 | -$16.25M | -$399K | $0 | $0 | $0 |
| Net Income | -$38.55M | $73.86M | $1.32M | $60.71M | $53.42M | $126.95M | $113.06M | $110.99M | $57.28M | $91.22M | $14.02M | $19.87M | -$92.27M | -$46.28M | $56M | -$38.46M | $460K | -$33.48M | -$17.27M |
| Net Income Margin | -5.4% | 11.2% | 0.2% | 9.1% | 9.2% | 24.4% | 28.8% | 27.1% | 19.0% | 42.4% | 9.7% | 16.3% | -767.7% | -3127.3% | 6974.2% | -36285.8% | 1.2% | -376.7% | -408.0% |
| Supplementary Data | |||||||||||||||||||
| EPS | -0.68 | 1.34 | 0.02 | 1.13 | 1.01 | 2.41 | 2.16 | 2.13 | 1.13 | 1.84 | 0.29 | 0.47 | -2.90 | -2.65 | 3.64 | -2.78 | -0.21 | -2.42 | -1.25 |
| Diluted EPS | -0.68 | 1.32 | 0.02 | 1.04 | 0.98 | 2.36 | 2.10 | 2.05 | 1.08 | 1.76 | 0.28 | 0.32 | -2.90 | -2.65 | 3.64 | -2.78 | -0.21 | -2.42 | -1.25 |
| Weighted Average OS | 56.45M | 55.10M | 54.54M | 53.67M | 53.10M | 52.62M | 52.41M | 51.99M | 50.76M | 49.47M | 47.49M | 42.26M | 31.82M | 17.44M | 13.86M | 13.86M | 13.86M | 13.86M | 13.86M |
| EBITDA | $42.53M | $178.28M | $90.04M | $153.36M | $129.19M | $210.54M | $176.85M | $151.51M | $107.67M | $56.62M | $21.77M | -$4.35M | -$83.68M | -$41.84M | -$36.73M | -$38.29M | $5.21M | -$23.69M | -$16.34M |
| EBITDA Margin | 5.9% | 26.9% | 14.8% | 23.0% | 22.3% | 40.5% | 45.0% | 37.1% | 35.6% | 26.3% | 15.1% | -3.6% | -696.2% | -2826.9% | -4573.5% | -36118.9% | 13.7% | -266.5% | -386.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 |
| Assets | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Cash and Cash Equivalents | $128.45M | $69.33M | $75.05M | $93.12M | $203.43M | $288.64M | $181.38M | $192.25M | $100.3M | $90.12M | $62.19M | $74.34M | $82.19M | $88.51M | $48.54M | $23.74M | $31.41M | $52.88M |
| Short-Term Investments | $180.22M | $384.28M | $179.82M | $368.21M | $136.25M | $133.89M | $165.69M | $163.77M | $39.74M | $0 | $0 | $0 | $0 | $0 | $0 | $8.96M | $35.12M | $7.5M |
| Cash and Short-Term Investments | $308.67M | $453.61M | $254.87M | $461.33M | $339.68M | $422.53M | $347.07M | $356.02M | $140.04M | $90.12M | $62.19M | $74.34M | $82.19M | $88.51M | $48.54M | $32.7M | $66.52M | $60.38M |
| Accounts Receivable | $187.8M | $142.08M | $144.16M | $165.5M | $148.93M | $140.88M | $87.33M | $102.92M | $65.59M | $41.53M | $25.91M | $17.27M | $5.05M | $675K | $0 | $158K | $3.74M | $2.28M |
| Inventory | $82.39M | $54.29M | $77.41M | $91.54M | $85.96M | $48.33M | $26.63M | $25.66M | $16.3M | $16.8M | $12.59M | $13.44M | $7.15M | $1.15M | $389K | $6.75M | $2.35M | $6.55M |
| Other Current Assets | $65.33M | $36.09M | $16.68M | $15.78M | $0 | $0 | $0 | $8.89M | $6.52M | $2.96M | $0 | $3.85M | $0 | $144K | $0 | $6.75M | $0 | $0 |
| Total Current Assets | $644.18M | $686.07M | $493.11M | $734.15M | $601.59M | $630.42M | $472.64M | $493.49M | $228.45M | $151.4M | $105.98M | $108.89M | $97.16M | $91.74M | $49.4M | $39.81M | $72.88M | $69.46M |
| Long-Term Assets | ||||||||||||||||||
| Property, Plant & Equipment Net | $10.53M | $11.54M | $13.53M | $15.17M | $16.95M | $37.82M | $17.07M | $4.09M | $5.12M | $4.34M | $3.87M | $2.45M | $2.55M | $1.42M | $1.31M | $1.25M | $1.86M | $1.99M |
| Goodwill | $124.88M | $117.02M | $117.02M | $117.02M | $117.52M | $77.91M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $569.46M | $521.91M | $599.89M | $702.46M | $784.69M | $364.34M | $24.84M | $31.37M | $36.02M | $16.49M | $976K | $5.43M | $1.16M | $683K | $912K | $1.14M | $1.37M | $1.6M |
| Long-Term Investments | $0 | $0 | $16.62M | $93.9M | $119.17M | $350.36M | $591.77M | $418.8M | $133.64M | $75.41M | $55.01M | $19.82M | $8.76M | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $38.35M | $0 | $0 | $0 | $0 | $0 | $32.06M | $29.68M | $20.84M | $41.73M | $22.5M | -$5.43M | -$153K | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $65.25M | $31.53M | $37.51M | $39.81M | $49.23M | $43.25M | $21.89M | $380K | $389K | $20.19M | $391K | $6.35M | $1.52M | $144K | $2.11M | $4.8M | $3.79M | $4.09M |
| Total Long-Term Assets | $808.47M | $682M | $784.56M | $968.36M | $1.09B | $873.68M | $687.64M | $484.32M | $196.01M | $158.16M | $82.75M | $28.62M | $13.83M | $2.25M | $4.33M | $7.2M | $7.02M | $7.68M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.45B | $1.37B | $1.28B | $1.7B | $1.69B | $1.5B | $1.16B | $977.81M | $424.46M | $309.57M | $188.73M | $137.51M | $111M | $93.99M | $53.73M | $47.01M | $79.9M | $77.13M |
| Liabilities | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accounts Payable | $2.68M | $4.59M | $1.96M | $10.54M | $9.33M | $6.15M | $10.14M | $3.19M | $6.84M | $8.05M | $4.31M | $1.86M | $3.14M | $2.81M | $10.08M | $11.26M | $6.25M | $4.47M |
| Short-Term Debt | $0 | $0 | $0 | $401.97M | $0 | $0 | $0 | $2.18M | $4.28M | $0 | $497K | $0 | $0 | $11.81M | $6.78M | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $2.44M | $12.38M | $15.94M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.18M | $287K | $209K | $176K | $143K | $8.09M | $508K | $232K | $0 | $0 | $0 |
| Other Current Liabilities | $98.72M | $68.56M | $77.08M | $54.95M | $93.04M | $55.99M | $14.47M | $22.99M | $17.03M | $63.33M | $26.79M | $19.7M | $10.16M | $7.86M | $1.55M | $2.5M | $1.29M | $2.5M |
| Total Current Liabilities | $338.17M | $292.4M | $290.2M | $687.96M | $315.38M | $245.11M | $160.59M | $161.35M | $123M | $80.74M | $56.1M | $27.49M | $26.4M | $22.98M | $18.77M | $15.21M | $10.03M | $8.27M |
| Long-Term Liabilities | ||||||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $379.25M | $361.75M | $345.17M | $329.46M | $22.26M | $4.17M | $7.08M | $26.95M | $34.39M | $11.09M | $22.71M | $75M | $75M | $75M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$31.46M | $1.15M | $1.5M | $1.39M | $1.27M | $1.42M | $309K | $465K | $0 | $0 | $437K |
| Long-Term Deferred Tax Liabilities | $0 | $4.96M | $24.96M | $49.81M | $85.36M | $35.22M | $0 | $31.46M | $14.96M | $114K | $854K | $6.56M | $12.64M | -$309K | $942K | $0 | $0 | -$75M |
| Other Long-Term Liabilities | $22.4M | $7.6M | $7.8M | $42.54M | $52.02M | $68.36M | $28.66M | $33.97M | $10.58M | $31.41M | $35.21M | $10.44M | $15.32M | $2.04M | $1.4M | $1.12M | $1.02M | $170K |
| Total Long-Term Liabilities | $52.76M | $39.94M | $65.96M | $128.35M | $557.92M | $514.14M | $404.27M | $363.44M | $33.98M | $37.07M | $13.76M | $38.66M | $51.13M | $13.44M | $25.52M | $76.12M | $76.02M | $75.61M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $390.93M | $332.34M | $356.16M | $816.3M | $873.3M | $759.24M | $564.85M | $524.79M | $156.98M | $117.81M | $69.86M | $66.15M | $77.53M | $36.42M | $44.29M | $91.33M | $86.06M | $83.88M |
| Stockholders' Equity | ||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $49K | $49K | $49K |
| Common Stock | $57K | $56K | $55K | $54K | $53K | $53K | $53K | $52K | $51K | $50K | $49K | $43K | $40K | $31K | $14K | $2K | $6K | $6K |
| Retained Earnings | $517.88M | $556.43M | $482.56M | $481.25M | $379.92M | $326.5M | $199.55M | $86.49M | -$26.82M | -$84.29M | -$144.64M | -$158.66M | -$178.53M | -$86.25M | -$39.97M | -$93.79M | -$55.32M | -$55.78M |
| Comprehensive Income & Other | -$44K | -$189K | -$593K | -$3.21M | $1.54M | $8.97M | $7.42M | -$3.16M | -$747K | -$134K | -$488K | -$154K | $0 | -$57K | $1K | $0 | $2K | -$2.15M |
| Other Stockholders' Equity | $543.78M | $479.25M | $438.9M | $404.9M | $435.88M | $418.31M | $395.83M | $366.48M | $294.25M | $275.99M | $263.47M | $229.97M | $211.95M | $143.79M | $49.4M | $49.46M | $49.16M | $49.03M |
| Total Equity | $1.06B | $1.04B | $921.52M | $886.2M | $815.85M | $744.86M | $595.43M | $453.02M | $267.48M | $191.75M | $118.88M | $71.35M | $33.46M | $57.57M | $9.44M | -$44.32M | -$6.16M | -$6.75M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.45B | $1.37B | $1.28B | $1.7B | $1.69B | $1.5B | $1.16B | $977.81M | $424.46M | $309.57M | $188.73M | $137.51M | $111M | $93.99M | $53.73M | $47.01M | $79.9M | $77.13M |
| Supplementary Data | ||||||||||||||||||
| Total Debt | $40.98M | $34.27M | $41.53M | $444.76M | $427.03M | $414.32M | $378.44M | $329.46M | $26.54M | $4.17M | $7.19M | $26.95M | $34.39M | $22.9M | $29.49M | $75M | $75M | $75M |
| Net Debt | -$87.47M | -$35.06M | -$33.53M | $351.64M | $223.59M | $125.69M | $197.05M | $137.21M | -$73.76M | -$85.96M | -$55M | -$47.39M | -$47.8M | -$65.61M | -$19.06M | $51.26M | $43.59M | $22.12M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
| Operating Activities | |||||||||||||||||||
| Net Income | -$38.55M | $73.86M | $1.32M | $60.71M | $53.42M | $126.95M | $113.06M | $110.99M | $57.28M | $91.22M | $14.02M | $19.87M | -$92.27M | -$46.28M | -$23.23M | -$39.08M | $4.14M | -$33.48M | -$17.27M |
| Depreciation & Amortization | $91.56M | $80.41M | $84.86M | $85.54M | $32.59M | $18.14M | $6.66M | $7.06M | $8.13M | $2.4M | $921K | $928K | $742K | $871K | $879K | $1.19M | $1.07M | $1.11M | $932K |
| Deferred Income Tax | $5.21M | -$20.14M | -$25.71M | -$26.32M | -$4.99M | $568K | -$5.83M | -$4.17M | $21.22M | -$41.79M | $2.15M | -$371K | $22.96M | $653K | -$16.25M | -$399K | -$4.59M | $0 | $0 |
| Stock-Based Compensation | $33.05M | $27.75M | $26.76M | $17.57M | $17.91M | $16.56M | $14.85M | $11.29M | $8.43M | $5.93M | $4.23M | $2.72M | $1.91M | $443K | -$82K | $297K | $111K | $99K | $74K |
| Changes in Working Capital: | |||||||||||||||||||
| Accounts Receivable | -$22.3M | $2.08M | $18.77M | -$16.37M | $3.87M | -$34.61M | $15.75M | -$35.86M | -$24.06M | -$15.62M | -$8.64M | -$12.22M | -$5.04M | -$11K | -$85K | $284K | -$329K | -$1.16M | -$414K |
| Inventory | -$7.5M | $15.81M | $6.11M | -$17.86M | -$14.58M | -$10.12M | -$969K | -$9.36M | $497K | -$4.21M | $854K | -$6.29M | -$6M | -$1.15M | $134K | $294K | -$322K | $2.49M | $25K |
| Accounts Payable | -$24.57M | -$15.02M | -$36.29M | -$19.16M | $18.18M | $8.27M | $6.96M | -$3.58M | -$620K | $3.47M | $2.06M | -$1.28M | $8.49M | -$1.1M | -$1.1M | $5.21M | $1.81M | $1.09M | $2.45M |
| Other Working Capital | -$20.79M | -$4.92M | $2.27M | $29.14M | -$3.9M | -$56K | -$21.13M | $44.05M | $47.89M | $24.81M | $15.79M | $2.28M | $8.23M | -$951K | $1.24M | $64K | $360K | $21K | $228K |
| Total Working Capital Change | -$75.16M | -$2.05M | -$9.14M | -$24.24M | $3.57M | -$36.52M | $613K | -$4.73M | $23.71M | $8.45M | $10.06M | -$17.5M | $5.67M | -$3.21M | $188K | $5.85M | $1.52M | $2.44M | $2.29M |
| Other Non-Cash Items | $31.22M | $12.11M | $33M | $3.57M | $24.62M | $12.69M | $13.79M | $8.54M | -$4.14M | $605K | $748K | $2.09M | $3.03M | $330K | $2.3M | -$408K | $382K | $179K | $0 |
| Net Cash from Operating | $47.33M | $171.95M | $111.08M | $116.83M | $127.13M | $138.4M | $143.13M | $128.99M | $114.64M | $66.81M | $32.12M | $7.73M | -$57.95M | -$47.2M | -$36.19M | -$32.54M | $2.63M | -$29.65M | -$13.98M |
| Investing Activities | |||||||||||||||||||
| Capital Expenditures | -$1.34M | -$725K | -$551K | -$412K | -$2.04M | -$3.45M | -$2.74M | -$844K | -$2.03M | -$1.6M | -$2.1M | -$593K | -$2.35M | -$753K | -$685K | -$294K | -$714K | -$135K | -$1.06M |
| Acquisitions | -$293.09M | $0 | $0 | -$14K | -$311.69M | -$313.54M | $0 | $0 | $0 | $0 | $0 | $0 | $705K | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$475.94M | -$688.01M | -$101.62M | -$406.99M | -$311.57M | -$95.89M | -$409.71M | -$491.65M | -$101.89M | -$47.36M | -$63.2M | -$53.26M | -$85.57M | -$97.67M | -$17.89M | -$32.78M | -$56.29M | -$89.51M | -$48.38M |
| Sales of Investments | $774.92M | $498.86M | $370.9M | $190.74M | $530.51M | $378.42M | $253.17M | $79.83M | $28.66M | $31.82M | $37.58M | $53.47M | $75.81M | $49.47M | $26.87M | $58.9M | $28.62M | $105.13M | $64.3M |
| Other Investing Activities | -$439K | $9K | $0 | $14K | $12.89M | -$241K | $1.35M | -$809K | -$11.15M | -$18.82M | -$8.51M | -$4.5M | -$705K | -$48.21M | $25.61M | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $4.11M | -$189.87M | $268.73M | -$216.66M | -$81.91M | -$34.7M | -$157.92M | -$413.48M | -$86.42M | -$35.96M | -$36.23M | -$4.89M | -$12.11M | -$48.96M | $33.9M | $25.82M | -$28.39M | $15.48M | $14.85M |
| Financing Activities | |||||||||||||||||||
| Debt Repaid | - | - | - | - | $137.51M | $802K | - | -$309.6M | - | - | - | - | $24.34M | $6.78M | -$30M | - | - | -$75M | - |
| Common Stock Issuance | $37.62M | $14.91M | $6.61M | $12.42M | $7.09M | $4.36M | $3.93M | $11.58M | $5.68M | $2.05M | $1.87M | $571K | $2.44M | $100.73M | $29K | $4K | $20K | $0 | $5K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$28.49M | -$2.71M | -$1.99M | -$22.9M | $0 | $0 | $0 | $55.25M | $0 | $0 | $0 | -$1K | -$2.92M | -$6.04M | -$2.94M | -$948K | $4.26M | -$10.54M | $0 |
| Net Cash from Financing | $9.13M | $12.19M | -$397.88M | -$10.48M | -$130.42M | $3.56M | $3.93M | $376.44M | $5.68M | $2.05M | $1.87M | $570K | $62.74M | $87.92M | $27.09M | -$944K | $4.28M | $64.46M | $5K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $60.57M | -$5.72M | -$18.07M | -$110.31M | -$85.21M | $107.26M | -$10.87M | $91.94M | $33.91M | $32.9M | -$2.24M | $3.42M | -$7.32M | -$8.24M | $24.8M | -$7.67M | -$21.47M | $50.29M | $879K |
| Supplementary Data | |||||||||||||||||||
| Operating Cash Flow | $47.33M | $171.95M | $111.08M | $116.83M | $127.13M | $138.4M | $143.13M | $128.99M | $114.64M | $66.81M | $32.12M | $7.73M | -$57.95M | -$47.2M | -$36.19M | -$32.54M | $2.63M | -$29.65M | -$13.98M |
| Capital Expenditure | -$1.34M | -$725K | -$551K | -$412K | -$2.04M | -$3.45M | -$2.74M | -$844K | -$2.03M | -$1.6M | -$2.1M | -$593K | -$2.35M | -$753K | -$685K | -$294K | -$714K | -$135K | -$1.06M |
| Free Cash Flow | $45.99M | $171.23M | $110.53M | $116.41M | $125.08M | $134.95M | $140.39M | $128.14M | $112.61M | $65.21M | $30.02M | $7.14M | -$60.3M | -$47.95M | -$36.87M | -$32.84M | $1.92M | -$29.79M | -$15.04M |
| Cash at Beginning | $69.33M | $75.05M | $93.12M | $203.43M | $288.64M | $181.38M | $192.25M | $100.3M | $66.4M | $33.5M | $36.4M | $32.98M | $40.3M | $48.54M | $23.74M | $31.41M | $52.88M | $2.59M | $1.71M |
| Cash at End | $129.9M | $69.33M | $75.05M | $93.12M | $203.43M | $288.64M | $181.38M | $192.25M | $100.3M | $66.4M | $34.15M | $36.4M | $32.98M | $40.3M | $48.54M | $23.74M | $31.41M | $52.88M | $2.59M |